Earnings Estimates Moving Higher for Hims & Hers Health (HIMS): Time to Buy?

Core Viewpoint - Hims & Hers Health, Inc. (HIMS) shows a significantly improving earnings outlook, making it a strong investment choice as analysts continue to raise earnings estimates for the company [1][2]. Current-Quarter Estimate Revisions - For the current quarter, Hims & Hers Health is expected to earn $0.10 per share, reflecting a remarkable change of +900% from the previous year's reported number [4]. - Over the last 30 days, five estimates have been revised upward with no negative revisions, leading to a Zacks Consensus Estimate increase of 98.61% [4]. Current-Year Estimate Revisions - For the full year, the company is projected to earn $0.47 per share, indicating a year-over-year change of +527.27% [5]. - In the past month, four estimates have been raised with no negative revisions, resulting in a consensus estimate increase of 17.36% [5]. Favorable Zacks Rank - The positive estimate revisions have earned Hims & Hers Health a Zacks Rank 2 (Buy), indicating strong potential for outperformance [6]. - Research indicates that stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) tend to significantly outperform the S&P 500 [6]. Bottom Line - The stock has gained 32.3% over the past four weeks, driven by solid estimate revisions, suggesting that the earnings growth prospects may lead to further stock price increases [7].